Art

J-GLOBAL ID：201902245908483601   Reference number：19A0962725

Impact of Sarcopenia as a Prognostic Biomarker of Bladder Cancer

膀胱癌の予後バイオマーカーとしてのサルコペニアの影響【JST・京大機械翻訳】

Author (4)： Fukushima Hiroshi (Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan) ,  Takemura Kosuke (Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan) ,  Suzuki Hiroaki (Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan) ,  Koga Fumitaka (Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677, Japan)
Material： International Journal of Molecular Sciences (Web)  (Int J Mol Sci (Web))
Volume： 19  Issue： 10  Page： 2999  Publication year： 2018 
JST Material Number： U7038A  ISSN： 1422-0067  CODEN： IJMCFK  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Sarcopenia, the degenerative a...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0962725&from=J-GLOBAL&jstjournalNo=U7038A") }}

Thesaurus term： *sarcopenia ,  literature review ,  complication ,  computed tomography ,  anorexia ,  metabolism ,  *biomarker ,  *prognosis ,  endocrine disease ,  nutritional state ,  human(primates) ,  drug therapy ,  nutrition disorder
Semi thesaurus term： 癌患者 ,  悪液質 ,  悪性腫瘍 , 【Automatic Indexing@JST】

Author keywords (5)： sarcopenia ,  prognosis ,  biomarker ,  bladder cancer ,  urothelial carcinoma

JST classification (3)： Diagnosis of tumors(=neoplasms)  (GE03020J) ,  Tumors(=neoplasms)of digestive system  (GH04000D) ,  Nucleic acids in general  (EB04010U)

Reference (76)：

• Antoni, S.; Ferlay, J.; Soerjomataram, I.; Znaor, A.; Jemal, A.; Bray, F. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends. Eur. Urol. 2017, 71, 96-108.
• Babjuk, M.; Bohle, A.; Burger, M.; Capoun, O.; Cohen, D.; Comperat, E.M.; Hernandez, V.; Kaasinen, E.; Palou, J.; Roupret, M.; et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur. Urol. 2017, 71, 447-461.
• Witjes, J.A.; Lebret, T.; Comperat, E.M.; Cowan, N.C.; De Santis, M.; Bruins, H.M.; Hernandez, V.; Espinos, E.L.; Dunn, J.; Rouanne, M.; et al. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur. Urol. 2017, 71, 462-475.
• Dalbagni, G.; Genega, E.; Hashibe, M.; Zhang, Z.F.; Russo, P.; Herr, H.; Reuter, V. Cystectomy for bladder cancer: A contemporary series. J. Urol. 2001, 165, 1111-1116.
• Bellmunt, J.; von der Maase, H.; Mead, G.M.; Skoneczna, I.; De Santis, M.; Daugaard, G.; Boehle, A.; Chevreau, C.; Paz-Ares, L.; Laufman, L.R.; et al. Randomized phase III study comparing paclitaxel/cisplatin/gemcitabine and gemcitabine/cisplatin in patients with locally advanced or metastatic urothelial cancer without prior systemic therapy: EORTC Intergroup Study 30987. J. Clin. Oncol. 2012, 30, 1107-1113.

Terms in the title (4)： 膀胱癌 ,  予後 ,  バイオマーカー ,  サルコペニア